UNH

UnitedHealth Group Incorporated

HEALTHCARE • MEDICAL - HEALTHCARE PLANS

Current Price $330.91 Target: $386.72

52-Week Range

$234.60 $606.36

Current price is 25.9% of 52-week range

Key Metrics

Market Cap $299.8B
P/E Ratio 16.7
Current Ratio 0.8
EPS $19.20
Dividend Yield 8.62%
Profit Margin 4.04%
Beta 0.4
PEG Ratio -0.9
ROE N/A
Operating Earnings Growth Rate -13.29%

Bullbiscuit Analysis

45

Overall Score

Score Breakdown

Good

Momentum Signal

Score Breakdown (what to buy)

Value 50
Growth 10
Financial Strength 43
Social Sentiment 75
AI Prediction 75

Momentum Score (when to buy)

Momentum Score 50

AI Overview

Last updated 6 days ago

UnitedHealth Group Incorporated (UNH) is a leading player in the healthcare sector, specifically within the medical healthcare plans industry. The company has a robust competitive moat, underpinned by its extensive network, diversified offerings, and significant scale, which provide cost advantages and high customer retention. Recent developments, such as re-establishing their full-year outlook and positive earnings revisions, signal management's confidence in navigating current market conditions. However, the industry faces challenges from regulatory changes and cost pressures, which could impact margins and profitability. UnitedHealth's strategic moves, including partnerships and branding initiatives, suggest a proactive approach to maintaining its competitive edge.

Financially, UnitedHealth presents a mixed picture. The P/E ratio of 32.62 suggests the market is pricing in significant growth, which may not align with the company's current net margin of 3.6%. The absence of a reported ROE raises questions about capital efficiency, though the debt/equity ratio of 0.83 indicates a balanced approach to leveraging its capital structure. However, a current ratio of 0.83 signals potential liquidity concerns, which could be problematic in meeting short-term obligations. The recent EPS trend and average earnings surprise suggest volatility in earnings performance, which could unsettle investors looking for stable growth. While the dividend yield appears anomalously high at 862.0%, this is likely a data error and should be verified for accuracy.

The investment thesis for UnitedHealth hinges on its market leadership and ability to adapt to industry dynamics. Over the next 12 months, key catalysts include the successful implementation of strategic partnerships and the impact of regulatory changes on healthcare costs. Risks involve potential margin compression due to increased competition and regulatory pressures. The company's ability to maintain its earnings momentum, as evidenced by recent outlook revisions, will be crucial in sustaining investor confidence.

Recommendation: HOLD. The two main reasons for this call are the company's strong market position and strategic initiatives, balanced against valuation concerns and potential liquidity issues. Investors should monitor regulatory developments and earnings consistency closely, as these factors will be pivotal in determining future stock performance.

Price & Profitability History

Log in